The impact of estrogen depletion by aromatase inhibitors on adiponectin serum levels in postmenopausal patients with breast cancer.
Georg Pfeiler(Medical University of Vienna), Peter Dubsky(Hirslanden Klinik St. Anna), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Robert Königsberg(Kaiser-Franz-Josef-Spital), Ruth Exner(Comprehensive Cancer Center Vienna), Sonja Vogl(Medical University of Vienna), Michael Seifert(Zimmer Biomet (Germany)), Peyman Hadji(Philipps University of Marburg), Andreas Berger(Comprehensive Cancer Center Vienna), Christian F. Singer(Comprehensive Cancer Center Vienna), Muy‐Kheng M. Tea(Medical University of Vienna), Florian Fitzal
Cited by 4
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k